Skip to main content
Top

Cancer Causes & Control

Issue 2/2003

Content (10 Articles)

Cancer in Indigenous Australians: a review

J.R. B.K. Condon, A. Barnes, J. Cunningham

Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States)

Kim-Anh Do, Marcella M. Johnson, Dorota A. Doherty, J. Jack Lee, Xi Feng Wu, Qiong Dong, Waun K. Hong, Fadlo R. Khuri, Karen K. Fu, Margaret R. Spitz

Occupation and the risk of adult glioma in the United States

A.J. De Roos, P.A. Stewart, M.S. Linet, E.F. Heineman, M. Dosemeci, T. Wilcosky, W.R. Shapiro, R.G. Selker, H.A. Fine, P.M. Black, P.D. Inskip

Breast cancers among very young premenopausal women (United States)

Michelle D. Althuis, Donna D. Brogan, Ralph J. Coates, Janet R. Daling, Marilie D. Gammon, Kathleen E. Malone, Janet B. Schoenberg, Louise A. Brinton

Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia)

M.P. Staples, G.G. Giles, D.R. English, M.R.E. McCredie, G. Severi, J.S. Cui, J.L. Hopper

Cancer incidence patterns in Koreans in the US and in Kangwha, South Korea

Scarlett Lin Gomez, Gem M. Le, Christina A. Clarke, Sally L. Glaser, Anne-Marie France, Dee W. West

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine